Qube Research & Technologies (QRT)
RMD icon

Qube Research & Technologies (QRT)’s ResMed RMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-142,863
Closed -$36.5M – 4021
2025
Q3 		$39.1M Buy
142,863
+36,154
+34% +$9.88M 0.04% 583
2025
Q2 		$27.5M Buy
+106,709
New +$25.5M 0.03% 713
2025
Q1 		– Sell
-7,324
Closed -$1.71M – 3816
2024
Q4 		$1.67M Sell
7,324
-75,842
-91% -$18.3M ﹤0.01% 1952
2024
Q3 		$20.3M Buy
83,166
+83,164
+4,158,200% +$18.6M 0.03% 657
2024
Q2 		$383 Sell
2
-1,070
-100% -$217K ﹤0.01% 3331
2024
Q1 		$212K Sell
1,072
-55,540
-98% -$10.2M ﹤0.01% 3000
2023
Q4 		$9.74M Sell
56,612
-317,444
-85% -$48.8M 0.02% 745
2023
Q3 		$55.3M Sell
374,056
-3,843
-1% -$695K 0.14% 183
2023
Q2 		$82.6M Buy
377,899
+288,385
+322% +$64.3M 0.3% 88
2023
Q1 		$19.6M Sell
89,514
-118,046
-57% -$25.6M 0.08% 253
2022
Q4 		$43.2M Buy
+207,560
New +$45.6M 0.23% 103
2022
Q1 		– Sell
-27,987
Closed -$7.29M – 2917
2021
Q4 		$7.29M Sell
27,987
-35,272
-56% -$9.15M 0.06% 441
2021
Q3 		$16.7M Buy
+63,259
New +$17.3M 0.21% 112
2021
Q2 		– Sell
-17,127
Closed -$3.32M – 2724
2021
Q1 		$3.32M Buy
+17,127
New +$3.43M 0.05% 467
2020
Q4 		– Sell
-68,767
Closed -$11.8M – 2141
2020
Q3 		$11.8M Buy
+68,767
New +$12.7M 0.17% 137
2019
Q2 		– Sell
-5,327
Closed -$554K – 538
2019
Q1 		$554K Buy
5,327
+1,415
+36% +$146K 0.07% 323
2018
Q4 		$445K Buy
3,912
+1,640
+72% +$176K 0.19% 142
2018
Q3 		$262K Buy
2,272
+841
+59% +$92.1K 0.03% 396
2018
Q2 		$148K Buy
+1,431
New +$145K 0.09% 217

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RMD Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of ResMed (RMD) in Q4 2025, closing a stake of 142,863 shares — an estimated $36.5M sold.

Qube Research & Technologies (QRT) first reported a position in RMD in Q2 2018 and held it in 19 quarters. The position peaked at $82.6M in Q2 2023. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 142,863 ResMed shares in Q4 2025, an estimated $36.5M.
  • Qube Research & Technologies (QRT) first reported a position in ResMed in Q2 2018 and held it in 19 quarters.
  • Qube Research & Technologies (QRT)'s ResMed position peaked at $82.6M in Q2 2023.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.